<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD10430000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P09960</UniProt_ID>
  <Seq_Length>611</Seq_Length>
  <Molecule_Weight>69285</Molecule_Weight>
  <KEGG_ID>hsa:4048</KEGG_ID>
  <Orthology_ID>K01254</Orthology_ID>
  <EBI_ID>EBI-721089</EBI_ID>
  <Function_Summary>Epoxide hydrolase that catalyzes the final step in the biosynthesis of the proinflammatory mediator leukotriene B4. Has also aminopeptidase activity.</Function_Summary>
  <Catalytic_Mechanism>(7E,9E,11Z,14Z)-(5S,6S)-5,6-epoxyicosa-7,9,11,14-tetraenoate + H(2)O = (6Z,8E,10E,14Z)-(5S,12R)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate.</Catalytic_Mechanism>
  <Pfam_ID>PF09127:Leuk-A4-hydro_C@@PF01433:Peptidase_M1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>14</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>3</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>LTA-4 hydrolase</Alias>
      <Alias>Leukotriene A(4) hydrolase</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of N-terminal amino acid residues from in a polypeptide chain.</Detail>
      <Keyword>Aminopeptidase activity</Keyword>
      <Ontology_ID>GO:0004177</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: an epoxide + H2O = a glycol.</Detail>
      <Keyword>Epoxide hydrolase activity</Keyword>
      <Ontology_ID>GO:0004301</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with zinc (Zn) ions.</Detail>
      <Keyword>Zinc ion binding</Keyword>
      <Ontology_ID>GO:0008270</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: H(2)O + leukotriene A(4) = leukotriene B(4).</Detail>
      <Keyword>Leukotriene-A4 hydrolase activity</Keyword>
      <Ontology_ID>GO:0004463</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.</Detail>
      <Keyword>Metallopeptidase activity</Keyword>
      <Ontology_ID>GO:0008237</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>131</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of peptides, compounds of 2 or more (but usually less than 100) amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another.</Detail>
      <Keyword>Peptide catabolic process</Keyword>
      <Ontology_ID>GO:0043171</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid.</Detail>
      <Keyword>Leukotriene biosynthetic process</Keyword>
      <Ontology_ID>GO:0019370</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.</Detail>
      <Keyword>Inflammatory response</Keyword>
      <Ontology_ID>GO:0006954</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>73</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>414</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>416</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>337</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>573</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD</Protein_Seq>
    <DNA_Seq>AAGAAACTTCCTTTCCCGGCGTGCACCGCGAATCCCTCCTCCTCTTCTTTACCTCTCTCCCTCCTCCTCAGGTTCTCTATCGACGAGTCTGGTAGCTGAGCGTTGGGCTGTAGGTCGCTGTGCTGTGTGATCCCCCAGAGCCATGCCCGAGATAGTGGATACCTGTTCGTTGGCCTCTCCGGCTTCCGTCTGCCGGACCAAGCACCTGCACCTGCGCTGCAGCGTCGACTTTACTCGCCGGACGCTGACCGGGACTGCTGCTCTCACGGTCCAGTCTCAGGAGGACAATCTGCGCAGCCTGGTTTTGGATACAAAGGACCTTACAATAGAAAAAGTAGTGATCAATGGACAAGAAGTCAAATATGCTCTTGGAGAAAGACAAAGTTACAAGGGATCGCCAATGGAAATCTCTCTTCCTATCGCTTTGAGCAAAAATCAAGAAATTGTTATAGAAATTTCTTTTGAGACCTCTCCAAAATCTTCTGCTCTCCAGTGGCTCACTCCTGAACAGACTTCTGGGAAGGAACACCCATATCTCTTTAGTCAGTGCCAGGCCATCCACTGCAGAGCAATCCTTCCTTGTCAGGACACTCCTTCTGTGAAATTAACCTATACTGCAGAGGTGTCTGTCCCTAAAGAACTGGTGGCACTTATGAGTGCTATTCGTGATGGAGAAACACCTGACCCAGAAGACCCAAGCAGGAAAATATACAAATTCATCCAAAAAGTTCCAATACCCTGCTACCTGATTGCTTTAGTTGTTGGAGCTTTAGAAAGCAGGCAAATTGGCCCAAGAACTTTGGTGTGGTCTGAGAAAGAGCAGGTGGAAAAGTCTGCTTATGAGTTTTCTGAGACTGAATCTATGCTTAAAATAGCAGAAGATCTGGGAGGACCGTATGTATGGGGACAGTATGACCTATTGGTCCTGCCACCATCCTTCCCTTATGGTGGCATGGAGAATCCTTGCCTTACTTTTGTAACTCCTACTCTACTGGCAGGCGACAAGTCACTCTCCAATGTCATTGCACATGAAATATCTCATAGCTGGACAGGGAATCTAGTGACCAACAAAACTTGGGATCACTTTTGGTTAAATGAGGGACATACTGTGTACTTGGAACGCCACATTTGCGGACGATTGTTTGGTGAAAAGTTCAGACATTTTAATGCTCTGGGAGGATGGGGAGAACTACAGAATTCGGTAAAGACATTTGGGGAGACACATCCTTTCACCAAACTTGTGGTTGATCTGACAGATATAGACCCTGATGTAGCTTATTCTTCAGTTCCCTATGAGAAGGGCTTTGCTTTACTTTTTTACCTTGAACAACTGCTTGGAGGACCAGAGATTTTCCTAGGATTCTTAAAAGCTTATGTTGAGAAGTTTTCCTATAAGAGCATAACTACTGATGACTGGAAGGATTTCCTGTATTCCTATTTTAAAGATAAGGTTGATGTTCTCAATCAAGTTGATTGGAATGCCTGGCTCTACTCTCCTGGACTGCCTCCCATAAAGCCCAATTATGATATGACTCTGACAAATGCTTGTATTGCCTTAAGTCAAAGATGGATTACTGCCAAAGAAGATGATTTAAATTCATTCAATGCCACAGACCTGAAGGATCTCTCTTCTCATCAATTGAATGAGTTTTTAGCACAGACGCTCCAGAGGGCACCTCTTCCATTGGGGCACATAAAGCGAATGCAAGAGGTGTACAACTTCAATGCCATTAACAATTCTGAAATACGATTCAGATGGCTGCGGCTCTGCATTCAATCCAAGTGGGAGGACGCAATTCCTTTGGCGCTAAAGATGGCAACTGAACAAGGAAGAATGAAGTTTACCCGGCCCTTATTCAAGGATCTTGCTGCCTTTGACAAATCCCATGATCAAGCTGTCCGAACCTACCAAGAGCACAAAGCAAGCATGCATCCCGTGACTGCAATGCTGGTGGGGAAAGACTTAAAAGTGGATTAAAGACCTGCGTATTGATGATTTTAGAGATTTCTCTTTTTTAAATGGAATTCGTAAAGAAATATAAAACTTCAGCTCACAATTAAAACTGTCTTTTTAGTTTTGGCTTTTTATTGTTTTGTTGGTGATTTTACTGAAATAAAGTTGAGCTACTTCTTCTTATAGTGGCATATTCTTTGTAAATTTTAACAAGGTTTAATCTTTTGATTTACAAATTAAAAAATTTTGAATTAGCTTTA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Fibroblasts</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>LTA4H</Gene_Name>
    <Gene_Alias>LTA4</Gene_Alias>
    <Gene_ID>4048</Gene_ID>
    <Genbank_ACCN>NM_000895</Genbank_ACCN>
    <Protein_ACCN>NP_000886</Protein_ACCN>
    <HGNC_ID>6710</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/4048</Gene_URL>
    <UCSC_ID>uc010suz.1</UCSC_ID>
    <EMBL_ID>ENSG00000111144</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P23508</Uniprot_ID>
      <Gene_Name>MCC</Gene_Name>
      <EBI_ID>EBI-307531</EBI_ID>
      <PPI_EBI_URL>EBI-721089,EBI-307531</PPI_EBI_URL>
      <Experiment_Number>1</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P01241</Uniprot_ID>
      <Gene_Name>GH1</Gene_Name>
      <EBI_ID>EBI-1026046</EBI_ID>
      <PPI_EBI_URL>EBI-721089,EBI-1026046</PPI_EBI_URL>
      <Experiment_Number>1</Experiment_Number>
    </PPI>
  </PPI_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Structure of human Leukotriene A4 hydrolase in complex with inhibitor sc57461A</PDB_Title>
      <PDB_ID>3U9W</PDB_ID>
      <Resolution>1.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3U9W</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of human Leukotriene A4 hydrolase in complex with inhibitor sc57461A</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with 1-[2-(1H-indol-5-yloxy)ethyl]piperidine-4-carboxylic acid</PDB_Title>
      <PDB_ID>3FUK</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FUK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH BESTATIN.</PDB_Title>
      <PDB_ID>1HS6</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HS6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation.</PubMed_Title>
      <Author>Thunnissen, M.M., et al.</Author>
      <Journal>Nat.Struct.Biol.(2001)8:131-135</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11175901?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of leukotriene a4 hydrolase in complex with 2-amino-N-[4-(phenylmethoxy)phenyl]-acetamide</PDB_Title>
      <PDB_ID>3CHO</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CHO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase.</PubMed_Title>
      <Author>Kirkland, T.A., et al.</Author>
      <Journal>Bioorg.Med.Chem.(2008)16:4963-4983</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18394906?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of leukotriene a4 hydrolase in complex with N5-[4-(phenylmethoxy)phenyl]-L-glutamine</PDB_Title>
      <PDB_ID>3CHQ</PDB_ID>
      <Resolution>2.09</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CHQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase.</PubMed_Title>
      <Author>Kirkland, T.A., et al.</Author>
      <Journal>Bioorg.Med.Chem.(2008)16:4963-4983</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18394906?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of leukotriene A4 hydrolase in complex with 4-amino-N-[4-(phenylmethoxy)phenyl]-butanamide</PDB_Title>
      <PDB_ID>3CHR</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CHR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase.</PubMed_Title>
      <Author>Kirkland, T.A., et al.</Author>
      <Journal>Bioorg.Med.Chem.(2008)16:4963-4983</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18394906?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with dihydroresveratrol</PDB_Title>
      <PDB_ID>3FTU</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FTU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with resveratrol</PDB_Title>
      <PDB_ID>3FTS</PDB_ID>
      <Resolution>2.33</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FTS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with (5-thiophen-2-ylthiophen-2-yl)methylamine</PDB_Title>
      <PDB_ID>3FU5</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FU5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with fragment N-(pyridin-3-ylmethyl)aniline</PDB_Title>
      <PDB_ID>3FTV</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FTV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of human Leukotriene A4 hydrolase in complex with inhibitor captopril</PDB_Title>
      <PDB_ID>4DPR</PDB_ID>
      <Resolution>2.02</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DPR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of human Leukotriene A4 hydrolase in complex with inhibitor captopril</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline</PDB_Title>
      <PDB_ID>3FUI</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FUI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF [E271Q] LEUKOTRIENE A4 HYDROLASE</PDB_Title>
      <PDB_ID>1H19</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1H19</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Leukotriene A4 Hydrolase/Aminopeptidase, Glutamate 271 is a Catalyticresidue with Specific Roles in Two Distinct Enzyme Mechanisms</PubMed_Title>
      <Author>Rudberg, P.C., et al.</Author>
      <Journal>J.Biol.Chem.(2002)277:1398</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11675384?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>COMPLEX OF HUMAN LEUKOTRIENE A4 HYDROLASE WITH A HYDROXAMIC ACID INHIBITOR</PDB_Title>
      <PDB_ID>2VJ8</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2VJ8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structures of Leukotriene A4 Hydrolase in Complex with Captopril and Two Competitive Tight-Binding Inhibitors</PubMed_Title>
      <Author>Thunnissen, M.M.G.M., et al.</Author>
      <Journal>Faseb J.(2002)16:1648</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12207002?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 Hydrolase complexed with inhibitor N-[3-(4-benzylphenoxy)propyl]-N-methyl-beta-alanine.</PDB_Title>
      <PDB_ID>3FHE</PDB_ID>
      <Resolution>2.16</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FHE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.</PubMed_Title>
      <Author>Sandanayaka, V., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:573-585</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19950900?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with dihydroresveratrol and bestatin</PDB_Title>
      <PDB_ID>3FTX</PDB_ID>
      <Resolution>1.96</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FTX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with fragment 4-(2-amino-1,3-thiazol-4-yl)phenol</PDB_Title>
      <PDB_ID>3FU3</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FU3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with fragment 3-(benzyloxy)pyridin-2-amine</PDB_Title>
      <PDB_ID>3FTY</PDB_ID>
      <Resolution>2.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FTY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with fragment 4-(4-fluorobenzoyl)pyridine</PDB_Title>
      <PDB_ID>3FU0</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FU0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with 5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole</PDB_Title>
      <PDB_ID>3FUJ</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FUJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>[E296Q]LTA4H in complex with RSR substrate</PDB_Title>
      <PDB_ID>3B7S</PDB_ID>
      <Resolution>1.47</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3B7S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-based dissection of the active site chemistry of leukotriene a4 hydrolase: implications for m1 aminopeptidases and inhibitor design.</PubMed_Title>
      <Author>Tholander, F., et al.</Author>
      <Journal>Chem.Biol.(2008)15:920-929</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18804029?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF [R563A] LEUKOTRIENE A4 HYDROLASE</PDB_Title>
      <PDB_ID>1SQM</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1SQM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Leukotriene A4 hydrolase: identification of a common carboxylate recognition site for the epoxide hydrolase and aminopeptidase substrates</PubMed_Title>
      <Author>Rudberg, P.C., et al.</Author>
      <Journal>J.Biol.Chem.(2004)279:27376-27382</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15078870?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with fragment (4-thiophen-2-ylphenyl)methanamine</PDB_Title>
      <PDB_ID>3FU6</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FU6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with fragment 5-hydroxyindole and bestatin</PDB_Title>
      <PDB_ID>3FUH</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FUH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of leukotriene A4 hydrolase in complex with (2S)-2-amino-5-[[4-[(2S)-2-hydroxy-2-phenyl-ethoxy]phenyl]amino]-5-oxo-pentanoic acid</PDB_Title>
      <PDB_ID>3CHS</PDB_ID>
      <Resolution>2.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CHS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase.</PubMed_Title>
      <Author>Kirkland, T.A., et al.</Author>
      <Journal>Bioorg.Med.Chem.(2008)16:4963-4983</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18394906?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 Hydrolase complexed with inhibitor 1-[2-(4-benzylphenoxy)ethyl]pyrrolidine.</PDB_Title>
      <PDB_ID>3FH8</PDB_ID>
      <Resolution>1.67</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FH8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.</PubMed_Title>
      <Author>Sandanayaka, V., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:573-585</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19950900?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase complexed with inhibitor RB3041</PDB_Title>
      <PDB_ID>2R59</PDB_ID>
      <Resolution>1.89</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2R59</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-based dissection of the active site chemistry of leukotriene a4 hydrolase: implications for m1 aminopeptidases and inhibitor design.</PubMed_Title>
      <Author>Tholander, F., et al.</Author>
      <Journal>Chem.Biol.(2008)15:920-929</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18804029?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>[E296Q]LTA4H in complex with Arg-Ala-Arg substrate</PDB_Title>
      <PDB_ID>3B7T</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3B7T</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-based dissection of the active site chemistry of leukotriene a4 hydrolase: implications for m1 aminopeptidases and inhibitor design.</PubMed_Title>
      <Author>Tholander, F., et al.</Author>
      <Journal>Chem.Biol.(2008)15:920-929</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18804029?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 Hydrolase complexed with inhibitor (2R)-2-[(4-benzylphenoxy)methyl]pyrrolidine.</PDB_Title>
      <PDB_ID>3FH5</PDB_ID>
      <Resolution>1.63</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FH5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.</PubMed_Title>
      <Author>Sandanayaka, V., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:573-585</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19950900?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF LEUKOTRIENE A4 HYDROLASE D375N MUTANT</PDB_Title>
      <PDB_ID>1GW6</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GW6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Leukotriene A4 Hydrolase: Selective Abrogation of Leukotriene B4 Formation by Mutation of Aspartic Acid 375</PubMed_Title>
      <Author>Rudberg, P.C., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2002)99:4215</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11917124?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 Hydrolase Complexed with Inhibitor RB3040</PDB_Title>
      <PDB_ID>3B7R</PDB_ID>
      <Resolution>1.81</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3B7R</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-based dissection of the active site chemistry of leukotriene a4 hydrolase: implications for m1 aminopeptidases and inhibitor design.</PubMed_Title>
      <Author>Tholander, F., et al.</Author>
      <Journal>Chem.Biol.(2008)15:920-929</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18804029?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of leukotriene a4 hydrolase in complex with (3S)-3-amino-4-oxo-4-[(4-phenylmethoxyphenyl)amino]butanoic acid</PDB_Title>
      <PDB_ID>3CHP</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CHP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase.</PubMed_Title>
      <Author>Kirkland, T.A., et al.</Author>
      <Journal>Bioorg.Med.Chem.(2008)16:4963-4983</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18394906?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 Hydrolase Complexed with KELatorphan</PDB_Title>
      <PDB_ID>3B7U</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3B7U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-based dissection of the active site chemistry of leukotriene a4 hydrolase: implications for m1 aminopeptidases and inhibitor design.</PubMed_Title>
      <Author>Tholander, F., et al.</Author>
      <Journal>Chem.Biol.(2008)15:920-929</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18804029?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with fragment 5-chloroindole and bestatin</PDB_Title>
      <PDB_ID>3FUE</PDB_ID>
      <Resolution>2.38</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FUE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with N-methyl-1-(2-thiophen-2-ylphenyl)methanamine</PDB_Title>
      <PDB_ID>3FUD</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FUD</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD10438009</ASD_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>19618939</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 Hydrolase complexed with inhibitor 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}pyrrolidin-1-yl]butanoate.</PDB_Title>
      <PDB_ID>3FH7</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FH7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.</PubMed_Title>
      <Author>Sandanayaka, V., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:573-585</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19950900?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with fragments N-(pyridin-3-ylmethyl)aniline and acetate</PDB_Title>
      <PDB_ID>3FTW</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FTW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with (R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol</PDB_Title>
      <PDB_ID>3FUM</PDB_ID>
      <Resolution>2.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FUM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with fragment 5-fluoroindole and bestatin</PDB_Title>
      <PDB_ID>3FUF</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FUF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with {4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone</PDB_Title>
      <PDB_ID>3FUN</PDB_ID>
      <Resolution>1.58</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FUN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.</PubMed_Title>
      <Author>Davies, D.R., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:4694-4715</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19618939?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanone</PDB_Title>
      <PDB_ID>3FUL</PDB_ID>
      <Resolution>2.39</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FUL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.</PubMed_Title>
      <Author>Sandanayaka, V., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:573-585</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19950900?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Leukotriene A4 hydrolase in complex with fragment 2-(pyridin-3-ylmethoxy)aniline</PDB_Title>
      <PDB_ID>3FTZ</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FTZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.</PubMed_Title>
      <Author>Sandanayaka, V., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:573-585</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19950900?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00590</Pathway_ID>
      <Pathway_Title>Arachidonic acid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <CATH_Class>Class 1: Mainly Alpha </CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1sqm</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,137,Gln;site,138,Ala;site,312,Trp;site,315,Phe;site,379,Tyr</Site_Detail>
      <Site_Reference>Davies DR, et al. J Med Chem. 2009 Aug 13;52(15):4694-715.</Site_Reference>
      <PDB_ID>3FTS;3FTU;3FTW;3FTX;3FTY;3FU0;3FU3;3FU5;3FU6;3FUD;3FUE;3FUF;3FUH;3FUI;3FUJ;3FUK;3FUM;3FUN</PDB_ID>
      <PubMed_ID>19618939</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.3.2.6</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/3/2/6.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00120001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01120129</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05250001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10438014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2013-05-13</Create_Date>
</Organism_Record>